Answers are grounded in this paper and cite their sources.
With the aging of populations worldwide, Alzheimer's disease (AD) has become a concern due to its high prevalence and the continued lack of established treatments. Early diagnosis is required as a preventive intervention to modify the disease's progression. In our previous study, we performed peptidomic analysis of serum samples obtained from AD patients and age-matched healthy subjects to seek peptide biomarker candidates for AD by using BLOTCHIP-MS analysis, and identified four peptides as AD biomarker candidates.
No takes yet. Share an insight, caveat, or question.
Fukui et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: